These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2891780)

  • 1. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
    Houghton AN; Albino AP; Cordon-Cardo C; Davis LJ; Eisinger M
    J Exp Med; 1988 Jan; 167(1):197-212. PubMed ID: 2891780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
    Morrison ME; Vijayasaradhi S; Engelstein D; Albino AP; Houghton AN
    J Exp Med; 1993 Apr; 177(4):1135-43. PubMed ID: 8096237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.
    Albino AP; Houghton AN; Eisinger M; Lee JS; Kantor RR; Oliff AI; Old LJ
    J Exp Med; 1986 Nov; 164(5):1710-22. PubMed ID: 2430046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes.
    Der JE; Dixon WT; Jimbow K; Horikoshi T
    Br J Cancer; 1993 Jan; 67(1):47-57. PubMed ID: 7678981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies.
    Thomson TM; Real FX; Murakami S; Cordon-Cardo C; Old LJ; Houghton AN
    J Invest Dermatol; 1988 Apr; 90(4):459-66. PubMed ID: 3280698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
    Houghton AN; Eisinger M; Albino AP; Cairncross JG; Old LJ
    J Exp Med; 1982 Dec; 156(6):1755-66. PubMed ID: 7175440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
    J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
    Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
    Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.
    Holzmann B; Johnson JP; Kaudewitz P; Riethmüller G
    J Exp Med; 1985 Feb; 161(2):366-77. PubMed ID: 3973533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
    Maeda K; Jimbow K
    Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture.
    Herlyn M; Rodeck U; Mancianti M; Cardillo FM; Lang A; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1987 Jun; 47(12):3057-61. PubMed ID: 3034401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M; Guerry D; Koprowski H
    J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein.
    Smoller BR; Hsu A; Krueger J
    J Cutan Pathol; 1991 Oct; 18(5):315-22. PubMed ID: 1761783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characteristics of cells derived from precursors of human melanoma.
    Herlyn M; Herlyn D; Elder DE; Bondi E; LaRossa D; Hamilton R; Sears HF; Balaban G; Guerry D; Clark WH
    Cancer Res; 1983 Nov; 43(11):5502-8. PubMed ID: 6616481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
    Vogel AM; Esclamado RM
    Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.